533 related articles for article (PubMed ID: 12842917)
21. Adaptive or maladaptive response to adenoviral adrenomedullin gene transfer is context-dependent in the heart.
Leskinen H; Rauma-Pinola T; Szokodi I; Kerkelä R; Pikkarainen S; Uusimaa P; Hautala T; Vuolteenaho O; Ruskoaho H
J Gene Med; 2008 Aug; 10(8):867-77. PubMed ID: 18615773
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular role of urotensin II: effect of chronic infusion in the rat.
Kompa AR; Thomas WG; See F; Tzanidis A; Hannan RD; Krum H
Peptides; 2004 Oct; 25(10):1783-8. PubMed ID: 15476946
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta.
Zhang YG; Hu YC; Mao YY; Wei RH; Bao SL; Wu LB; Kuang ZJ
Chin Med J (Engl); 2010 Dec; 123(24):3634-9. PubMed ID: 22166643
[TBL] [Abstract][Full Text] [Related]
24. Collagen remodeling after myocardial infarction in the rat heart.
Cleutjens JP; Verluyten MJ; Smiths JF; Daemen MJ
Am J Pathol; 1995 Aug; 147(2):325-38. PubMed ID: 7639329
[TBL] [Abstract][Full Text] [Related]
25. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of angiotensin AT1a receptors mRNA in the heart and renal medulla after myocardial infarction in rats.
Milik E; Szczepańska-Sadowska E; Cudnoch-Jedrzejewska A; Dobruch J; Morton M; Koperski L
J Physiol Pharmacol; 2006 Sep; 57(3):375-88. PubMed ID: 17033091
[TBL] [Abstract][Full Text] [Related]
27. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.
Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH
Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction.
El-Sabban ME; Hassan KA; Birbari AE; Bitar KM; Bikhazi AB
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):369-78. PubMed ID: 11967826
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse.
Wang HX; Zeng XJ; Liu Y; Wang J; Lu LQ; Hao G; Zhang LK; Tang CS
Regul Pept; 2009 Apr; 154(1-3):85-90. PubMed ID: 19323985
[TBL] [Abstract][Full Text] [Related]
30. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
[TBL] [Abstract][Full Text] [Related]
31. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
[TBL] [Abstract][Full Text] [Related]
32. Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats.
Maki T; Kawahara Y; Tanonaka K; Yagi A; Takeo S
Planta Med; 2002 Dec; 68(12):1103-7. PubMed ID: 12494338
[TBL] [Abstract][Full Text] [Related]
33. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker.
Rakowski E; Hassan GS; Dhanak D; Ohlstein EH; Douglas SA; Giaid A
J Mol Cell Cardiol; 2005 Nov; 39(5):785-91. PubMed ID: 16171813
[TBL] [Abstract][Full Text] [Related]
34. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
35. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.
Langham RG; Kelly DJ; Gow RM; Zhang Y; Dowling JK; Thomson NM; Gilbert RE
Am J Kidney Dis; 2004 Nov; 44(5):826-31. PubMed ID: 15492948
[TBL] [Abstract][Full Text] [Related]
36. A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart.
Luosujärvi H; Aro J; Tokola H; Leskinen H; Tenhunen O; Skoumal R; Szokodi I; Ruskoaho H; Rysä J
Blood Press; 2010 Feb; 19(1):54-63. PubMed ID: 20175653
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.
Li H; Shi S; Sun YH; Zhao YJ; Li QF; Li HZ; Wang R; Xu CQ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):312-8. PubMed ID: 18986329
[TBL] [Abstract][Full Text] [Related]
38. [Expressions of urotensin II and its receptor in pulmonary arteries in rats with chronic thromboembolic pulmonary hypertension].
Zhang YM; Liu WJ; Shi YZ; Gao YF; Wang LL; Chen MX
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):37-41. PubMed ID: 18366905
[TBL] [Abstract][Full Text] [Related]
39. Urotensin II inhibits the proliferation but not the differentiation of cardiac side population cells.
Gong H; Ma H; Liu M; Zhou B; Zhang G; Chen Z; Jiang G; Yan Y; Yang C; Kanda M; Wu J; Yuan J; Li L; Nagai T; Komuro I; Ge J; Zou Y
Peptides; 2011 May; 32(5):1035-41. PubMed ID: 21291940
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli.
Mustonen E; Pohjolainen V; Aro J; Pikkarainen S; Leskinen H; Ruskoaho H; Rysä J
Blood Press; 2009; 18(5):286-93. PubMed ID: 19919401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]